Deciphera DCC-2618 gastrointestinal stromal tumour

Deciphera completes enrolment in Phase III trial of DCC-2618

Deciphera Pharmaceuticals has completed enrolment in the Phase III INVICTUS clinical trial to examine the safety, tolerability and efficacy of…